Nanotechnology Now - News Story: Biophage Pharma appoints Dr. Pearl Chin to Board of Directors

Home > News > Biophage Pharma appoints Dr. Pearl Chin to Board of Directors

October 4th, 2005

Biophage Pharma appoints Dr. Pearl Chin to Board of Directors

Abstract:
Biophage Pharma is pleased to announce the appointment of Dr. Pearl Chin to its Board of Directors. Dr.
Chin is the founder and managing Director of Seraphima Ventures, a private equity fund focused on Nanotechnology.

Source:
newswire

Bookmark:

Related News Press

Announcements

INRS and ELI deepen strategic partnership to train the next generation in laser science:PhD students will benefit from international mobility and privileged access to cutting-edge infrastructure June 6th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025

Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025

A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025

Appointments/Promotions/New hires/Resignations/Deaths

The National Space Society Mourns the Passing of Robert Krone, Founder of the Kepler Space Institute: Krone's Visionary and Humanistic Approach to the Study of Space Communities and Settlement Was Unique September 22nd, 2021

Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021

JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021

The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020



Premium Products


	Only the news you want to read! Learn More



	Full-service, expert consulting Learn More




	The latest news from around the world, FREE